Australian Research Australia has been leading the way with SCN2A research, both in outlining the clinical features and developing precision based treatments. Latest Posts Natural history studies and clinical trial readiness for genetic developmental and epileptic encephalopathies December 30, 2021 No Comments Natural history studies are critical for clinical trial design & registration of new treatments for developmental epileptic encephalopathies. Read More » ASO for SCN2A gain of function mutation in mice December 6, 2021 No Comments Gene-based therapy using ASO-mediated mRNA was very effective in a mouse model of SCN2A. Read More » SCN2A International Natural History Study July 18, 2021 No Comments Help understand SCN2A by enrolling in this natural history study which is open to participants from any country. Read More »
Natural history studies and clinical trial readiness for genetic developmental and epileptic encephalopathies December 30, 2021 No Comments Natural history studies are critical for clinical trial design & registration of new treatments for developmental epileptic encephalopathies. Read More »
ASO for SCN2A gain of function mutation in mice December 6, 2021 No Comments Gene-based therapy using ASO-mediated mRNA was very effective in a mouse model of SCN2A. Read More »
SCN2A International Natural History Study July 18, 2021 No Comments Help understand SCN2A by enrolling in this natural history study which is open to participants from any country. Read More »